|
|||||
|
|
The authors respond |
|
| Authors: | Gilles Plourde Denis Prud��homme |
| Affiliation: | Drug Safety Unit — Director’s Office (Plourde), Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics, Biologic and Genetic Therapies Directorate, Health Canada, Ottawa, Ont.; the School of Human Kinetics (Prud’homme), Faculty of Health Sciences, University of Ottawa, Ottawa, Ont.; and Médicine du sport (Prud’homme), Gatineau, Que. |
| Abstract: | |
| Keywords: | |